MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production.
Given its solid fundamentals, strong balance sheet, steady cash flow generation, and promising growth outlook, Whitecap Resources appears well-positioned to appeal to income-focused investors seeking both stability and long-term return potential.
Solar panel manufacturer First Solar (NASDAQ:FSLR) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.1% year on year to $1.68 billion. On the other hand, the company’s full-year revenue guidance of $5.05 billion at the midpoint came in 17.4% below analysts’ estimates. Its GAAP profit of $4.84 per share was 6.3% below analysts’ consensus estimates.
Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 20.9% year on year to $275 million. Its GAAP profit of $0.04 per share was $0.01 above analysts’ consensus estimates.
Payment technology company Marqeta (NASDAQ:MQ) announced better-than-expected revenue in Q4 CY2025, with sales up 26.7% year on year to $172.1 million. The company expects next quarter’s revenue to be around $164.1 million, close to analysts’ estimates. Its GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Global payments company Flywire (NASDAQ:FLYW) announced better-than-expected revenue in Q4 CY2025, with sales up 39.7% year on year to $157.5 million. Its GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Beer company Boston Beer (NYSE:SAM) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 4.1% year on year to $385.7 million. Its GAAP loss of $2.12 per share was 15.3% above analysts’ consensus estimates.
Marketing technology company Zeta Global (NYSE:ZETA) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 25.4% year on year to $394.6 million. Guidance for next quarter’s revenue was optimistic at $370 million at the midpoint, 2.1% above analysts’ estimates.
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.1% year on year to $1.20 billion. On the other hand, the company’s full-year revenue guidance of $4.38 billion at the midpoint came in 2.8% below analysts’ estimates. Its non-GAAP profit of $6.64 per share was 2.1% above analysts’ consensus estimates.
Snap stock has seen much better days, but the fundamentals tell a more complicated story. Discover whether this is a value trap or a rare turnaround opportunity.
Data analytics and digital solutions company ExlService Holdings (NASDAQ:EXLS) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 12.7% year on year to $542.6 million. On the other hand, the company’s full-year revenue guidance of $2.3 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.50 per share was 7.5% above analysts’ consensus estimates.
Latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 44.6% year on year to $8.76 billion. Its GAAP profit of $11.03 per share was 3.6% below analysts’ consensus estimates.
